Literature DB >> 23746481

Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Italo Porto1, Giovanni Luigi De Maria, Antonio Maria Leone, Ilaria Dato, Domenico D'Amario, Francesco Burzotta, Giampaolo Niccoli, Carlo Trani, Luigi Marzio Biasucci, Leonardo Bolognese, Filippo Crea.   

Abstract

Endothelial progenitor cells (EPCs) are released from the bone marrow during cardiac ischemic events, potentially influencing vascular and myocardial repair. We assessed the clinical and angiographic correlates of EPC mobilization at the time of primary percutaneous coronary intervention in 78 patients with ST elevation myocardial infarction and the impact of both baseline and follow-up EPC levels on left ventricular (LV) remodeling. Blood samples were drawn from the aorta and the culprit coronary artery for cytofluorimetric EPC detection (CD34+CD45dimKDR+ cells, in percentage of cytofluorimetric counts). Area at risk was assessed by Bypass Angioplasty Revascularization Investigation myocardial jeopardy index, thrombotic burden as thrombus score and microvascular obstruction (MVO) as a combination of ST segment resolution and myocardial blush grade. Echocardiographic evaluation of LV remodeling was performed at 1-year follow-up in 54 patients, whereas peripheral EPC levels were reassessed in 40 patients. EPC levels during primary percutaneous coronary intervention were significantly higher in intracoronary than in aortic blood (0.043% vs 0.0006%, p <0.001). Both intracoronary and aortic EPC were related to area at risk extent, to intracoronary thrombus score (p <0.001), and inversely to MVO (p = 0.001). Peripheral EPC levels at 1-year follow-up were lower in patients with LV remodeling than in those without (0.001% [0.001 to 0.002] vs 0.003% [0.002 to 0.010]; p = 0.01) and independently predicted absence of remodeling at multivariate analysis. In conclusion, a rapid intracoronary EPC recruitment takes place in the early phases of ST elevation myocardial infarction, possibly reflecting an attempted reparative response. The extent of this mobilization seems to be correlated to the area at risk and to the amount of MVO. Persistently low levels of EPC are associated to LV remodeling.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23746481     DOI: 10.1016/j.amjcard.2013.04.056

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Intrinsic Vascular Repair by Endothelial Progenitor Cells in Acute Coronary Syndromes: an Update Overview.

Authors:  Vânia Leal; Carlos Fontes Ribeiro; Bárbara Oliveiros; Natália António; Sónia Silva
Journal:  Stem Cell Rev Rep       Date:  2019-02       Impact factor: 5.739

2.  Period2 deficiency blunts hypoxia-induced mobilization and function of endothelial progenitor cells.

Authors:  Tao Qin; Yuan-Yuan Sun; Wen-Wu Bai; Bo Wang; Yi-Fan Xing; Yan Liu; Rui-Xue Yang; Yu-Xia Zhao; Jian-Min Li
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

3.  Clinical efficacy and safety of autologous stem cell transplantation for patients with ST-segment elevation myocardial infarction.

Authors:  Rong Li; Xiao-Ming Li; Jun-Rong Chen
Journal:  Ther Clin Risk Manag       Date:  2016-08-01       Impact factor: 2.423

4.  Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome.

Authors:  Catherine Gebhard; Eric Rhéaume; Colin Berry; Geneviève Brand; Anne-Elen Kernaleguen; Gabriel Théberge-Julien; Mohammad Afaque Alam; Candace Y W Lee; Laurianne Boileau; Malorie Chabot-Blanchet; Marie-Claude Guertin; Marc-André Lavoie; Jean Grégoire; Réda Ibrahim; Philippe L'Allier; Jean-Claude Tardif
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

5.  Dose-dependent impact of statin therapy intensity on circulating progenitor cells in patients undergoing percutaneous coronary intervention for the treatment of acute versus chronic coronary syndrome.

Authors:  Roberta Florescu; Elisa Liehn; Nicole Schaaps; Jörg Schröder; Mohammad Almalla; Sebastian Mause; Anne Cornelissen; Felix Vogt
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.240

Review 6.  Regenerative Therapy for Cardiomyopathies.

Authors:  Zi Wang; Xuan Su; Muhammad Ashraf; Il-Man Kim; Neal L Weintraub; Meng Jiang; Yaoliang Tang
Journal:  J Cardiovasc Transl Res       Date:  2018-05-09       Impact factor: 4.132

7.  How does coronary stent implantation impact on the status of the microcirculation during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction?

Authors:  Giovanni Luigi De Maria; Florim Cuculi; Niket Patel; Sam Dawkins; Gregor Fahrni; George Kassimis; Robin P Choudhury; John C Forfar; Bernard D Prendergast; Keith M Channon; Rajesh K Kharbanda; Adrian P Banning
Journal:  Eur Heart J       Date:  2015-08-07       Impact factor: 29.983

8.  The relationship between oxidised LDL, endothelial progenitor cells and coronary endothelial function in patients with CHD.

Authors:  Jonathan Watt; Simon Kennedy; Nadeem Ahmed; James Hayhurst; John D McClure; Colin Berry; Roger M Wadsworth; Keith G Oldroyd
Journal:  Open Heart       Date:  2016-01-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.